NCT02720939View on ClinicalTrials.gov

ASD-specific Induced Pluripotent Stem Cells for Disease Modeling

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Autism Spectrum Disorder
Trial Locations (1)

Unknown

National Taiwan Univeristy Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT02720939 - ASD-specific Induced Pluripotent Stem Cells for Disease Modeling | Biotech Hunter | Biotech Hunter